JP2013524213A5 - - Google Patents

Download PDF

Info

Publication number
JP2013524213A5
JP2013524213A5 JP2013502539A JP2013502539A JP2013524213A5 JP 2013524213 A5 JP2013524213 A5 JP 2013524213A5 JP 2013502539 A JP2013502539 A JP 2013502539A JP 2013502539 A JP2013502539 A JP 2013502539A JP 2013524213 A5 JP2013524213 A5 JP 2013524213A5
Authority
JP
Japan
Prior art keywords
sample
complement activation
human
assay
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013502539A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013524213A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2011/050369 external-priority patent/WO2011123044A1/en
Publication of JP2013524213A publication Critical patent/JP2013524213A/ja
Publication of JP2013524213A5 publication Critical patent/JP2013524213A5/ja
Pending legal-status Critical Current

Links

JP2013502539A 2010-03-31 2011-03-30 炎症をもたらす組織分解を検出する方法 Pending JP2013524213A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1050310 2010-03-31
SE1050310-0 2010-03-31
PCT/SE2011/050369 WO2011123044A1 (en) 2010-03-31 2011-03-30 Method to detect tissue degradation leading to inflammation

Publications (2)

Publication Number Publication Date
JP2013524213A JP2013524213A (ja) 2013-06-17
JP2013524213A5 true JP2013524213A5 (enExample) 2014-05-08

Family

ID=44712493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013502539A Pending JP2013524213A (ja) 2010-03-31 2011-03-30 炎症をもたらす組織分解を検出する方法

Country Status (5)

Country Link
US (1) US20130084584A1 (enExample)
EP (1) EP2553465A4 (enExample)
JP (1) JP2013524213A (enExample)
AU (1) AU2011233753A1 (enExample)
WO (1) WO2011123044A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3771468A1 (en) * 2019-07-31 2021-02-03 Universitätsklinikum Hamburg-Eppendorf C3/c5 convertase assays

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4642284A (en) * 1983-06-13 1987-02-10 Scripps Clinic And Research Foundation Method and system for detection of complement pathway activation
SE452065B (sv) * 1986-04-11 1987-11-09 Ulf R Nilsson Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning
IL84160A0 (en) * 1986-10-16 1988-03-31 Vasocor Method and kit for immune complex assay
EP0888551A1 (en) * 1996-03-19 1999-01-07 Akzo Nobel N.V. Method for predicting the outcome of hepatitis b infection
SE9904236D0 (sv) * 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab Immunoassay
WO2004043237A2 (en) * 2002-11-08 2004-05-27 Barnes-Jewish Hospital Uncoupled collagen synthesis and degradation assays
EP1766411B1 (en) * 2004-05-24 2011-02-23 AnaMar AB Method for determining a tissue degradation process by detection of comp neoepitopes
AU2008262048B2 (en) * 2007-06-07 2013-09-26 Genentech, Inc. C3b antibodies and methods for the prevention and treatment of complement- associated disorders
BRPI0813262A2 (pt) * 2007-06-20 2015-04-14 Schering Corp Biomarcadores de destruição de articulação para terapia de doença inflamatória de articulação anti-il-17a
EP2307451B1 (en) * 2008-03-21 2016-05-25 Universiteit Hasselt Biomarkers for rheumatoid arthritis

Similar Documents

Publication Publication Date Title
Vashist et al. One-step kinetics-based immunoassay for the highly sensitive detection of C-reactive protein in less than 30 min
Wang et al. Competitive immunoassays for the detection of small molecules using single molecule arrays
JP2019530875A5 (enExample)
Dinkelaar et al. Global coagulation tests: their applicability for measuring direct factor Xa-and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
Leligdowicz et al. Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection
JP2019535015A5 (enExample)
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
JP2019516966A5 (enExample)
Lehner et al. Methodological and preanalytical evaluation of an HMGB1 immunoassay
WO2013132347A3 (en) Improved elisa immunoassay for calprotectin
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2012509477A5 (enExample)
WO2008063663A3 (en) Poly (ethylene glycol) anti-body detection assays and kits for performing thereof
JP2012073260A5 (enExample)
JP2015230280A5 (enExample)
Shah et al. Calibration-free concentration analysis of protein biomarkers in human serum using surface plasmon resonance
Liu et al. Preparation of a peptide-modified electrode for capture and voltammetric determination of endotoxin
Madhurantakam et al. Multiplex sensing of IL-10 and CRP towards predicting critical illness in COVID-19 infections
RU2012148244A (ru) Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления
JP2015505371A5 (enExample)
JP2016511407A5 (enExample)
Zhang et al. Detection of TNF-α using the established ab-MPs-CLIA
Hardy et al. Is lupus anticoagulant testing with dilute Russell’s viper venom clotting times reliable in the presence of inflammation?
Wu et al. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology
Kuno et al. LecT-Hepa: A triplex lectin–antibody sandwich immunoassay for estimating the progression dynamics of liver fibrosis assisted by a bedside clinical chemistry analyzer and an automated pretreatment machine